Member Info for gixer

RNS

but yet again no holdings RNS from DSM.

What makes them above the regulations

Alfista, Re: "Funding of 2 years worth of estimated demand will be a challenge"

By my (very rough) estimates it has taken 2 years to use up DSM stock that was valued at around 1 million Euros and we still have a fair amount of stock having just received the last batch. So...... with price increases etc then I would guess we might need 1 million euros for enough stock for 2 years.

Also

"The production process for Fruitflow II SD takes place in two stages, which need to be booked with its outsourced supply chain partners in advance of production taking place. The Company is in close dialogue with all key parties in its supply chain for Fruitflow, to include (i) maximum capacity planning, (ii) production cost and other efficiencies and (iii) the potential requirement for much larger batches of Fruitflow II SD to be made at relatively short notice."

Much larger batches than 2 years worth. I like that thought.

Cash of £189k at 31 March 2024

Cash of £478k at 30 September 2024

It was 12:48 last year.

And patents only last so long

Wonder if they are waiting on the patent to be granted before human trials are started on this one. Or Have they started already????

The clock will be ticking.

"USE OF WATER-SOLUBLE TOMATO CONCENTRATE IN PREPARATION OF COMPOSITION FOR TREATING CEREBRAL ISCHEMIA-REPERFUSION INJURY"

Publication Date 26.12.2024

"Abstract

(EN) A use of water-soluble tomato concentrate in the preparation of a drug for preventing or treating cerebral ischemia-reperfusion injury or in the preparation of a composition for preventing or treating cerebral ischemia-reperfusion injury. After long-term research, on the basis of neurological function evaluation, tetrazolium red staining and HE staining, the researchers first found and proved that water-soluble tomato concentrate has a significant repair effect on ischemic stroke reperfusion injury, can significantly reduce the cerebral infarction area, lower the neurological deficits score and improve the brain tissue pathology, and can be applied to the preparation of a composition for preventing or treating cerebral ischemia-reperfusion injury."

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2024260450&_cid=P11-M56J4Y-92631-1

Jumped the gun a little with this one?????

"In addition, the company has made breakthroughs in the development of cardiovascular health functional products, launching innovative products with "Qingluosu" as the core, filling many gaps in the domestic health food field. "

https://www.sohu.com/a/841674448_121952740

https://www-sohu-com.translate.goog/a/841674448_121952740?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

"In terms of new functions, By-Health has established a new function evaluation and mechanism research system to develop new and important function products. For example, By-Health's self-developed "Fruitflow" is a new function that helps cardiovascular health. By establishing relevant evaluation and testing methods and conducting research on the mechanism of Fruitflow in improving blood flow health, it provides consumers with more accurate cardiovascular health solutions."

https://baijiahao.baidu.com/s?id=1819473069977155762&wfr=spider&for=pc

https://baijiahao-baidu-com.translate.goog/s?id=1819473069977155762&wfr=spider&for=pc&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp

Thanks DP64, will do.

Have a great Christmas everyone.

To be fair, I don't think Dr_H was saying that he was expecting all that to be in the interim results :)

What we do know is that Fruitflow II SD sales where more than £724k for the six months ending on 30 September 2024 and confirmed sales orders for Fruitflow II SD in excess of £190k where being processed. Should see us break the £1 million + for the year end in March.

Hopefully we will get an update on sales from Sept to Dec and the £190k figure will be substantially :) higher. More info on the new production run of Fruitflow will also be welcome.

December 19, 2024

Still giving little away.

Q: How is the progress of the new function application submitted by the company last year?

According to the "Implementation Rules for New Functions and Product Technical Evaluation of Health Foods (Trial)", the application process for new function application and product registration of health food mainly includes material acceptance, technical evaluation and evaluation conclusion, submission to the State Administration for Market Regulation, inclusion in the health function catalog, and approval of new function health food. At present, the new function application materials have been received.

https://data.eastmoney.com/notices/detail/300146/AN202412191641364497.html

If that's the end of DSM stock then I would assume it was somewhere in the region of £300k.

From memory DSM was holding around 1 million euros of stock at the time.

I would just like to say that even though I wrongly assumed some of the royalty payment had been paid 😖 I still think IF has pulled a rabbit out the hat with yesterdays RNS.

Hopefully get some additional info regarding the new production run in the interim results.

BB, yes I think you are right.

It doesn't stop me from being disappointed though as I thought the majority of this royalty payment had already been made.

I agree BB that the final results showed that royalties could have been around £129k and were reported in cost of goods.

"The year ended 31 March 2024 therefore included nine months of the royalty at the first year rate to 31 December 2023, and three months of the royalty at the lower second year rate. Royalties payable to DSM are included in cost of goods."

But today we are told.....

"Provexis and dsm-firmenich have agreed that the estimated royalty for the two years ended 31 December 2024 will be settled in new ordinary shares of 0.1p each in the Company (the 'New Provexis Shares'). "

Forgive me if I am being stupid but it does sound like we have paid the majority of the royalty twice.

Yes Dr_H, all a bit confusing.

Included in cost of goods in the results but now paying in shares 🤔

IMO

If By-Health had obtained Blue Hat for a Fruitflow product under one of the existing health claims then they wont launch any FF products until they get the health claim and product registrations that they have applied for.

Again IMO, A FF product launch with the first new health claim will get far greater publicity and free marketing.

As Dr_H says, we are unlikely to get notification of Blue Cap approval on any existing health function claim like Blood Pressure reduction. The new permitted Health Function claim application is a different story though as this is the first and the media if not By-Health themselves will want to report this important milestone.

"Looking forward to the cut and paste" You must be the only one.

I am looking forward to some good news regarding By-Health or gut health or a major new customer or breaking into profit or...... but until that happens there is not much we can do.